Table 2 General features of the trials which were included
Trials | No of patients treated by rivaroxaban (n) | No of patients in the placebo group (n) | Time period of patients’ enrollment | Bias risk score |
|---|---|---|---|---|
ATLAS-ACS 2 TIMI 51 | 10,229 | 5113 | 2008–2011 | 10 |
GEMINI-ACS-1 | 1519 | 1518 | 2015–2016 | 10 |
COMPASS | 9152 | 9126 | 2013–2016 | 10 |
ATLAS-ACS-TIMI 46 | 2331 | 1160 | 2006–2008 | 10 |
Total no of patients (n) | 23,231 | 16,917 |